NHNCXQUTVMIFBE-YRFRWJCTSA-N
C20H16ClF3N8O3S — CID 129211816
Data last refreshed: (MolForge compound catalog, from PubChem)
About NHNCXQUTVMIFBE-YRFRWJCTSA-N
NHNCXQUTVMIFBE-YRFRWJCTSA-N (PubChem CID 129211816) has the molecular formula C20H16ClF3N8O3S and a molecular weight of 540.92 g/mol. Its IUPAC name is N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-[(1R)-1-[[hydroxy-[6-(5-methyl-1,3,4-oxadiazol-2-yl)pyrimidin-4-yl]methyl]amino]ethyl]-1,3-thiazole-5-carboxamide.
Molecular Properties
| Compound Name | NHNCXQUTVMIFBE-YRFRWJCTSA-N |
|---|---|
| PubChem CID | 129211816 |
| Molecular Formula | C20H16ClF3N8O3S |
| Molecular Weight | 540.92 g/mol |
| Exact Mass | 540.07 |
| IUPAC Name | N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-2-[(1R)-1-[[hydroxy-[6-(5-methyl-1,3,4-oxadiazol-2-yl)pyrimidin-4-yl]methyl]amino]ethyl]-1,3-thiazole-5-carboxamide |
| SMILES | Cc1nnc(-c2cc(C(O)N[C@H](C)c3ncc(C(=O)Nc4cc(C(F)(F)F)c(Cl)cn4)s3)ncn2)o1 |
| InChI | InChI=1S/C20H16ClF3N8O3S/c1-8(29-16(33)12-4-13(28-7-27-12)18-32-31-9(2)35-18)19-26-6-14(36-19)17(34)30-15-3-10(20(22,23)24)11(21)5-25-15/h3-8,16,29,33H,1-2H3,(H,25,30,34)/t8-,16?/m1/s1 |
| InChIKey | NHNCXQUTVMIFBE-YRFRWJCTSA-N |
| XLogP | 3.95 |
| TPSA | 151.84 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 540.92 |
| LogP ≤ 5 | 3.95 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 129211816 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.